Initially identified in melanoma, BRAF mutations have since been detected in multiple solid tumors, including CRC, non-small-cell lung cancer (NSCLC), thyroid carcinoma, biliary tract cancers (BTCs), and gastrointestinal stromal tumors (GISTs), as well as in certain hematologic malignancies and pediatric tumors. The gene discussed is BRAF; the disease is melanoma.